Ogimi, Chikara http://orcid.org/0000-0002-2166-8152
Krantz, Elizabeth M.
Golob, Jonathan L.
Liu, Catherine http://orcid.org/0000-0002-7532-4822
Waghmare, Alpana http://orcid.org/0000-0003-2268-9470
Akramoff, Ashley
Mallory, Anthony
Leisenring, Wendy M. http://orcid.org/0000-0001-7405-0906
Jerome, Keith R. http://orcid.org/0000-0002-8212-3789
Chow, Victor A.
Pergam, Steven A.
Fredricks, David N.
Englund, Janet A.
Boeckh, Michael
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (K23AI139385)
U.S. Department of Health & Human Services | National Institutes of Health (CA18029, R01HL081595, K24HL093294)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 10 May 2022
Revised: 9 August 2022
Accepted: 11 August 2022
First Online: 5 September 2022
Competing interests
: AW reports grant support from Ansun Biopharma, Allovir, VB Tech, Amazon, Inc, GlaxoSmithKline and Pfizer, and is an Advisory Board Member for Kyorin Pharmaceutical. JAE reports grant support from AstraZeneca, Merck, Pfizer, GlaxoSmithKline and Novavax, an Advisory Board Member and consultant for Sanofi Pasteur, Meissa Vaccines, Teva Pharmaceuticals and Astra Zeneca. MB reports grant support from Amazon, GSK, Janssen, Gilead and VirBio, and a consultant for Allovir, Merck, Janssen, Gilead, Kyorin Pharmaceuticals, and VirBio, and an Advisory Board Member for Evrys Bio. All other authors report no potential conflicts. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.